Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function

Neurobiology of Aging

Volumn 35, Issue 8, 2014, Pages 1839-1849

  Ari, Csilla ^a,b   Borysov, Sergiy I ^a,b,c   Wu, Jiashin ^b   Padmanabhan, Jaya ^a,b   Potter, Huntington ^a,b,d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Abeta peptide; Alzheimer's disease; Down syndrome; Eg5; Kinesin 5; Microtubules; Neurite outgrowth; Neurodegeneration; Neurotransmitter receptor; Neurotrophin receptor; NMDA receptor; P75

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM; KINESIN 5; MONASTROL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROTRANSMITTER RECEPTOR; NEUROTROPHIN; NEUROTROPHIN RECEPTOR P75; EG5 PROTEIN, MOUSE; GLUTAMIC ACID; KINESIN; PYRIMIDINE DERIVATIVE; THIOKETONE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANTIBODY LABELING; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CELL SURFACE; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOPRECIPITATION; LONG TERM POTENTIATION; MITOSIS; MOUSE; NERVE FIBER GROWTH; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TRANSGENIC MOUSE; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; CELL CULTURE; COGNITION; DRUG EFFECTS; FEMALE; GENETICS; MEMORY; METABOLISM; MOLECULARLY TARGETED THERAPY; NERVE CELL PLASTICITY; NEURITE; PATHOLOGY; PC12 CELL LINE; PHYSIOLOGY; PREGNANCY; PSYCHOLOGY; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CALCIUM; CELLS, CULTURED; COGNITION; FEMALE; GLUTAMIC ACID; KINESIN; LONG-TERM POTENTIATION; MEMORY; MICE; MICE, TRANSGENIC; MOLECULAR TARGETED THERAPY; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; NEURITES; NEURONAL PLASTICITY; PC12 CELLS; PREGNANCY; PYRIMIDINES; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NEUROTRANSMITTER; THIONES;

EID: 84899897219     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.02.006     Document Type: Article

References (69)

1. Abisambra J.F., Fiorelli T., Padmanabhan J., Neame P., Wefes I., Potter H. LDLR expression and localization are altered in mouse and human cell culture models of Alzheimer's disease. PLoS One 2010, 5:e8556.
2. Almeida C.G., Tampellini D., Takahashi R.H., Greengard P., Lin M.T., Snyder E.M., Gouras G.K. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 2005, 20:187-198.
3. Arendt T., Bruckner M.K., Mosch B., Losche A. Selective cell death of hyperploid neurons in Alzheimer's disease. Am. J. Pathol. 2010, 177:15-20.
4. Baas P.W. The role of motor proteins in establishing the microtubule arrays of axons and dendrites. J.Chem. Neuroanat. 1998, 14:175-180.
5. Boeras D.I., Granic A., Padmanabhan J., Crespo N.C., Rojiani A.M., Potter H. Alzheimer's presenilin 1 causes chromosome missegregation and aneuploidy. Neurobiol. Aging 2008, 29:319-328.
6. Borysov S.I., Granic A., Padmanabhan J., Norden M., Walsczak C., Potter H. Alzheimer's Aβ disrupts formation and stability of the mitotic spindle and directly inhibits mitotic/neuronal microtubule motors. Cell Cycle 2011, 10:1397-1410.
7. Bui N.T., König H.G., Culmsee C., Bauerbach E., Poppe M., Krieglstein J., Prehn J.H. p75 neurotrophin receptor is required for constitutive and NGF-induced survival signalling in PC12 cells and rat hippocampal neurones. J.Neurochem. 2002, 81:594-605.
8. Capsoni S., Ugolini G., Comparini A., Ruberti F., Berardi N., Cattaneo A. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc. Natl. Acad. Sci. U.S.A 2000, 97:6826-6831.
9. Chakravarthy B., Gaudet C., Ménard M., Atkinson T., Brown L., Laferla F.M., Armato U., Whitfield J. Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. J.Alzheimers Dis. 2010, 19:915-925.
10. Cullen W.K., Suh Y.H., Anwyl R., Rowan M.J. Block of LTP in rat hippocampus invivo by beta-amyloid precursor protein fragments. Neuroreport 1997, 8:3213-3217.
11. Eimer W.A., Vassar R. Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and caspase-3 activation. Mol. Neurodegener. 2013, 8:2.
12. Feuk L., McCarthy S., Andersson B., Prince J.A., Brookes A.J. Mutation screening of a haplotype block around the insulin degrading enzyme gene and association with Alzheimer's disease. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2005, 136B:69-71.
13. Geller L.N., Potter H. Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease. Neurobiol. Dis. 1999, 6:167-179.
14. Gladding C.M., Raymond L.A. Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function. Mol. Cell. Neurosci. 2011, 48:308-320.
15. Granic A., Padmanabhan J., Norden M., Potter H. Alzheimer Abeta peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: requirement for tau and APP. Mol. Biol. Cell 2010, 21:511-520.
16. Granic A., Potter H. Down syndrome model of Alzheimer's disease: beyond trisomy 21 nondisjunction. Genetics and Etiology of Down Syndrome 2011, 159-176. InTech, Croatia. S. Dey (Ed.).
17. Hamano T., Mutoh T., Tabira T., Araki W., Kuriyama M., Mihara T., Yano S., Yamamoto H. Abnormal intracellular trafficking of high affinity nerve growth factor receptor, Trk, in stable transfectants expressing presenilin 1 protein. Brain Res. Mol. Brain Res. 2005, 137:70-76.
18. Hardy J. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J.Neurochem. 2009, 110:1129-1134.
19. Heald R., Walczak C.E. Microtubule-based motor function in mitosis. Curr. Opin. Struct. Biol. 1999, 9:268-274.
20. Hefti F., Dravid A., Hartikka J. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res. 1984, 293:305-309.
21. Honda T., Nihonmatsu N., Yasutake K., Ohtake A., Sato K., Tanaka S., Murayama O., Murayama M., Takashima A. Familial Alzheimer's disease-associated mutations block translocation of full-length presenilin 1 to the nuclear envelope. Neurosci. Res. 2000, 37:101-111.
22. Hsu T.C., Satya-Prakash K.L. Aneuploidy induction by mitotic arrestants in animal cell systems: possible mechanisms. Basic Life Sci. 1985, 36:279-289.
23. Hu X., Crick S.L., Bu G., Frieden C., Pappu R.V., Lee J.M. Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc. Natl. Acad. Sci. U.S.A 2009, 106:20324-20329.
24. Huber L.J., Chao M.V. Mesenchymal and neuronal cell expression of the p75 neurotrophin receptor are distinguished during morphogenesis of transgenic animals. Dev. Biol. 1995, 167:227-238.
25. Iourov I.Y., Vorsanova S.G., Liehr T., Yurov Y.B. Aneuploidy in the normal, Alzheimer's disease and ataxia-telangiectasia brain: differential expression and pathological meaning. Neurobiol. Dis. 2009, 34:212-220.
26. Jung K.M., Tan S., Landman N., Petrova K., Murray S., Lewis R., Kim P.K., Kim D.S., Ryu S.H., Chao M.V., Kim T.W. Regulated intramembrane proteolysis of the p75 neurotrophin receptor modulates its association with the TrkA receptor. J.Biol. Chem. 2003, 278:42161-42169.
27. Kapoor T.M., Mayer T.U., Coughlin M.L., Mitchison T.J. Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5. J.Cell Biol. 2000, 150:975-988.
28. Lee V.M. Regulation of tau phosphorylation in Alzheimer's disease. Ann. N.Y. Acad. Sci. 1996, 777:107-113.
29. Lee V.M., Trojanowski J.Q. Progress from Alzheimer's tangles to pathological tau points towards more effective therapies now. J.Alzheimers Dis. 2006, 9(3 Suppl):257-262.
30. Li J., Xu M., Zhou H., Ma J., Potter H. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 1997, 90:917-927.
31. Liu S.J., Gasperini R., Foa L., Small D.H. Amyloid-beta decreases cell-surface AMPA receptors by increasing intracellular calcium and phosphorylation of GluR2. J.Alzheimers Dis. 2010, 21:655-666.
32. Liu Y.L., Peterson D.A., Schubert D. Amyloid b peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc. Natl. Acad. Sci. U.S.A 2008, 95:13266-13271.
33. Liu Y., Zhang Y.W., Wang X., Zhang H., You X., Liao F.F., Xu H. Intracellular trafficking of presenilin 1 is regulated by beta-amyloid precursor protein and phospholipase D1. J.Biol. Chem. 2009, 284:12145-12152.
34. Mailhes J.B., Mastromatteo C., Fuseler J.W. Transient exposure to the Eg5 kinesin inhibitor monastrol leads to syntelic orientation of chromosomes and aneuploidy in mouse oocytes. Mutat. Res. 2004, 559:153-167.
35. Mandelkow E.M., Mandelkow E. Tau in Alzheimer's disease. Trends Cell Biol. 1998, 8:425-427.
36. Matrone C., Ciotti M.T., Mercanti D., Marolda R., Calissano P. NGF and BDNF signaling control amyloidogenic route and Aβ production in hippocampal neurons. Proc. Natl. Acad. Sci U.S.A 2008, 105:13139-13144.
37. Mazumdar M., Sundareshan S., Misteli T. Human chromokinesin KIF4A functions in chromosome condensation and segregation. J.Cell Biol. 2004, 166:613-620.
38. Migliore L., Botto N., Scarpato R., Petrozzi L., Cipriani G., Bonuccelli U. Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients. Cytogenet. Cell Genet. 1999, 87:41-46.
39. Mufson E.J., Counts S.E., Perez S.E., Ginsberg S.D. Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Rev. Neurother. 2008, 8:1703-1718.
40. Padmanabhan J., Levy M., Dickson D.W., Potter H. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Brain 2006, 129:3020-3034.
41. Parkhurst C.N., Zampieri N., Chao M.V. Nuclear localization of the p75 neurotrophin receptor intracellular domain. J.Biol. Chem. 2010, 285:5361-5368.
42. Pigino G., Pelsman A., Mori H., Busciglio J. Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation. J.Neurosci. 2001, 21:834-842.
43. Poduslo J.F., Gilles E.J., Ramakrishnan M., Howell K.G., Wengenack T.M., Curran G.L., Kandimalla K.K. HH domain of Alzheimer's disease Abeta provides structural basis for neuronal binding in PC12 and mouse cortical/hippocampal neurons. PLoS One 2010, 5:e8813.
44. Potter H. Review and hypothesis: Alzheimer disease and Down syndrome-chromosome 21 nondisjunction may underlie both disorders. Am. J. Hum. Genet. 1991, 48:1192-1200.
45. Potter H., Ma J., Das S., Geller L.N., Benjamin M., Kayyali U.S., Dressler D. Beyond beta-protein: new steps in the pathogenic pathway to Alzheimer's disease. Research Advances in Alzheimer's Disease and Related Disorders 1995, 643-654. John Wiley and Sons Ltd., New York. J.A. Mortimer, K. Iqbal, B. Winblad, H.M. Wisniewski (Eds.).
46. Potter H., Wisniewski T. Apolipoprotein E: essential catalyst of the Alzheimer amyloid cascade. Internat. J. Alz. Dis. 2012, 2012:489428.
47. Rapoport M., Dawson H.N., Binder L.I., Vitek M.P., Ferreira A. Tau is essential to beta -amyloid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A 2002, 99:6364-6369.
48. Reitz C., Cheng R., Schupf N., Lee J.H., Mehta P.D., Rogaeva E., St George-Hyslop P., Mayeux R. Association between variants in IDE-KIF11-HHEX and plasma amyloid beta levels. Neurobiol. Aging 2012, 33:e13-e17.
49. Roberson E.D., Scearce-Levie K., Palop J.J., Yan F., Cheng I.H., Wu T., Gerstein H., Yu G.Q., Mucke L. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 2007, 316:750-754.
50. Ruberti F., Capsoni S., Comparini A., Di Daniel E., Franzot J., Gonfloni S., Rossi G., Berardi N., Cattaneo A. Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J.Neurosci. 2000, 20:2589-2601.
51. Saavedra L., Mohamed A., Ma V., Kar S., de Chaves E.P. Internalization of beta-amyloid peptide by primary neurons in the absence of apolipoprotein E. J.Biol. Chem. 2007, 282:35722-35732.
52. Shah S.B., Nolan R., Davis E., Stokin G.B., Niesman I., Canto I., Glabe C., Goldstein L.S. Examination of potential mechanisms of amyloid-induced defects in neuronal transport. Neurobiol. Dis. 2009, 346:11-25.
53. Smith J.P., Lal V., Bowser D., Cappai R., Masters C.L., Ciccotosto G.D. Stimulus pattern dependence of the Alzheimer's disease amyloid-β 42 peptide's inhibition of long term potentiation in mouse hippocampal slices. Brain Res. 2009, 1269:176-184.
54. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., Greengard P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 2005, 8:1051-1058.
55. Takemura R., Nakata T., Okada Y., Yamazaki H., Zhang Z., Hirokawa N. mRNA expression of KIF1A, KIF1B, KIF2, KIF3A, KIF3B, KIF4, KIF5, and cytoplasmic dynein during axonal regeneration. J.Neurosci. 1996, 16:31-35.
56. Tang Y., Scott D.A., Das U., Edland S.D., Radomski K., Koo E.H., Roy S. Early and selective impairments in axonal transport kinetics of synaptic cargoes induced by soluble amyloid β-protein oligomers. Traffic 2012, 13:681-693.
57. Tezapsidis N., Merz P.A., Merz G., Hong H. Microtubular interactions of presenilin direct kinesis of Abeta peptide and its precursors. FASEB. J. 2003, 17:1322-1324.
58. Tong L., Balazs R., Thornton P.L., Cotman C.W. Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J.Neurosci. 2004, 24:6799-6809.
59. Townsend M., Shankar G.M., Mehta T., Walsh D.M., Selkoe D.J. Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity: a potent role for trimmers. J.Physiol. 2006, 572:477-492.
60. Tuszynski M.H., Thal L., Pay M., Salmon D.P., U H.S., Bakay R., Patel P., Blesch A., Vahlsing H.L., Ho G., Tong G., Potkin S.G., Fallon J., Hansen L., Mufson E.J., Kordower J.H., Gall C., Conner J. Aphase I clinical trial of nerve growth factor gene therapy for Alzheimer's disease. Nat. Med. 2005, 11:551-555.
61. Wakana Y., Villeneuve J., van Galen J., Cruz-Garcia D., Tagaya M., Malhotra V. Kinesin-5/Eg5 is important for transport of CARTS from the trans-Golgi network to the cell surface. J.Cell Biol. 2013, 202:241-250.
62. Walczak C.E., Heald R. Mechanisms of mitotic spindle assembly and function. Int. Rev. Cytol. 2008, 265:111-158.
63. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation invivo. Nature 2002, 416:535-539.
64. Wang Y., Greig N.H., Yu Q.S., Mattson M.P. Presenilin-1 mutation impairs cholinergic modulation of synaptic plasticity and suppresses NMDA currents in hippocampus slices. Neurobiol. Aging 2009, 30:1061-1068.
65. Wang H.W., Pasternak J.F., Kuo H., Ristic H., Lambert M.P., Chromy B., Viola K.L., Klein W.L., Stine W.B., Krafft G.A., Trommer B.L. Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res. 2002, 924:133-140.
66. Winton M.J., Lee E.B., Sun E., Wong M.M., Leight S., Zhang B., Trojanowski J.Q., Lee V.M. Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration. J.Neurosci. 2011, 31:7691-7699.
67. Yang T. Small molecule, non-peptide p75 ligands inhibit Abeta-induced neurodegeneration and synaptic impairment. PLoS One 2008, 3:e3604.
68. Yoon E.J., Park H.J., Kim G.Y., Cho H.M., Choi J.H., Park H.Y., Jang J.Y., Rhim H.S., Kang S.M. Intracellular amyloid beta interacts with SOD1 and impairs the enzymatic activity of SOD1: implications for the pathogenesis of amyotrophic lateral sclerosis. Exp. Mol. Med. 2009, 41:611-617.
69. Youmans K.L., Tai L.M., Kanekiyo T., Stine W.B., Michon S.C., Nwabuisi-Heath E., Manelli A.M., Fu Y., Riordan S., Eimer W.A., Binder L., Bu G., Yu C., Hartley D.M., LaDu M.J. Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody. Mol. Neurodegener. 2012, 7:8.